A biopharmaceutical research company with ties in Andover has laid off a third of its workforce as one of the leaders in gene therapy goes through a “strategic ...

Separately, Sareptea said last week that it would pause the development of most of its experimental gene therapies for a different type of muscular dystrophy. The stoppage came after one of the ...

Cleveland’s public hospital system cites soaring charity care costs, pandemic relief expiration, and looming bond payments as key drivers of the cuts.

Sarepta stock plunged again Thursday on a report the FDA will require additional clinical testing to validate the safety ...

This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...